FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4384341146> ?p ?o ?g. }

• W4384341146 endingPage "5389" @default.
• W4384341146 startingPage "5389" @default.
• W4384341146 abstract "The development of novel scaffolds that can increase the effectiveness, safety, and convenience of medication therapy using drug conjugates is a promising strategy. As a result, drug conjugates are an active area of research and development in medicinal chemistry. This research demonstrates acetamide-sulfonamide scaffold preparation after conjugation of ibuprofen and flurbiprofen with sulfa drugs, and these scaffolds were then screened for urease inhibition. The newly designed conjugates were confirmed by spectroscopic techniques such as IR, 1HNMR, 13CNMR, and elemental analysis. Ibuprofen conjugated with sulfathiazole, flurbiprofen conjugated with sulfadiazine, and sulfamethoxazole were found to be potent and demonstrated a competitive mode of urease inhibition, with IC50 (µM) values of 9.95 ± 0.14, 16.74 ± 0.23, and 13.39 ± 0.11, respectively, and urease inhibition of 90.6, 84.1, and 86.1% respectively. Ibuprofen conjugated with sulfanilamide, sulfamerazine, and sulfacetamide, whereas flurbiprofen conjugated with sulfamerazine, and sulfacetamide exhibited a mixed mode of urease inhibition. Moreover, through molecular docking experiments, the urease receptor-binding mechanisms of competitive inhibitors were anticipated, and stability analysis through MD simulations showed that these compounds made stable complexes with the respective targets and that no conformational changes occurred during the simulation. The findings demonstrate that conjugates of approved therapeutic molecules may result in the development of novel classes of pharmacological agents for the treatment of various pathological conditions involving the urease enzyme." @default.
• W4384341146 created "2023-07-15" @default.
• W4384341146 creator A5001106991 @default.
• W4384341146 creator A5007598907 @default.
• W4384341146 creator A5032882613 @default.
• W4384341146 creator A5070355599 @default.
• W4384341146 creator A5071575769 @default.
• W4384341146 creator A5077782134 @default.
• W4384341146 creator A5081895684 @default.
• W4384341146 creator A5090405839 @default.
• W4384341146 creator A5091353538 @default.
• W4384341146 date "2023-07-13" @default.
• W4384341146 modified "2023-10-16" @default.
• W4384341146 title "New Acetamide-Sulfonamide-Containing Scaffolds: Antiurease Activity Screening, Structure-Activity Relationship, Kinetics Mechanism, Molecular Docking, and MD Simulation Studies" @default.
• W4384341146 cites W118179289 @default.
• W4384341146 cites W1918277650 @default.
• W4384341146 cites W192509002 @default.
• W4384341146 cites W1976499671 @default.
• W4384341146 cites W2029667189 @default.
• W4384341146 cites W2032044839 @default.
• W4384341146 cites W2034065147 @default.
• W4384341146 cites W204666009 @default.
• W4384341146 cites W2066009213 @default.
• W4384341146 cites W2069123478 @default.
• W4384341146 cites W2118233996 @default.
• W4384341146 cites W2130541969 @default.
• W4384341146 cites W2342807093 @default.
• W4384341146 cites W2593843857 @default.
• W4384341146 cites W2625992912 @default.
• W4384341146 cites W2770794472 @default.
• W4384341146 cites W2802605869 @default.
• W4384341146 cites W2805248373 @default.
• W4384341146 cites W2808858297 @default.
• W4384341146 cites W2885269063 @default.
• W4384341146 cites W2888538927 @default.
• W4384341146 cites W2896776118 @default.
• W4384341146 cites W3001350232 @default.
• W4384341146 cites W3019330545 @default.
• W4384341146 cites W3038029973 @default.
• W4384341146 cites W3046468150 @default.
• W4384341146 cites W3046751266 @default.
• W4384341146 cites W3107347249 @default.
• W4384341146 cites W3134097060 @default.
• W4384341146 cites W3152834571 @default.
• W4384341146 cites W4224942856 @default.
• W4384341146 cites W4256118173 @default.
• W4384341146 cites W4296458526 @default.
• W4384341146 cites W4307272925 @default.
• W4384341146 cites W4316037186 @default.
• W4384341146 cites W4318763065 @default.
• W4384341146 cites W4318939459 @default.
• W4384341146 cites W4319599235 @default.
• W4384341146 doi "https://doi.org/10.3390/molecules28145389" @default.
• W4384341146 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37513261" @default.
• W4384341146 hasPublicationYear "2023" @default.
• W4384341146 type Work @default.
• W4384341146 citedByCount "1" @default.
• W4384341146 countsByYear W43843411462023 @default.
• W4384341146 crossrefType "journal-article" @default.
• W4384341146 hasAuthorship W4384341146A5001106991 @default.
• W4384341146 hasAuthorship W4384341146A5007598907 @default.
• W4384341146 hasAuthorship W4384341146A5032882613 @default.
• W4384341146 hasAuthorship W4384341146A5070355599 @default.
• W4384341146 hasAuthorship W4384341146A5071575769 @default.
• W4384341146 hasAuthorship W4384341146A5077782134 @default.
• W4384341146 hasAuthorship W4384341146A5081895684 @default.
• W4384341146 hasAuthorship W4384341146A5090405839 @default.
• W4384341146 hasAuthorship W4384341146A5091353538 @default.
• W4384341146 hasBestOaLocation W43843411461 @default.
• W4384341146 hasConcept C112613896 @default.
• W4384341146 hasConcept C159110408 @default.
• W4384341146 hasConcept C178790620 @default.
• W4384341146 hasConcept C181199279 @default.
• W4384341146 hasConcept C185592680 @default.
• W4384341146 hasConcept C21951064 @default.
• W4384341146 hasConcept C2776730177 @default.
• W4384341146 hasConcept C2777990680 @default.
• W4384341146 hasConcept C2778269047 @default.
• W4384341146 hasConcept C2779521917 @default.
• W4384341146 hasConcept C2779944601 @default.
• W4384341146 hasConcept C2781000538 @default.
• W4384341146 hasConcept C2781039511 @default.
• W4384341146 hasConcept C41685203 @default.
• W4384341146 hasConcept C501593827 @default.
• W4384341146 hasConcept C521977710 @default.
• W4384341146 hasConcept C55493867 @default.
• W4384341146 hasConcept C71240020 @default.
• W4384341146 hasConcept C71924100 @default.
• W4384341146 hasConcept C98274493 @default.
• W4384341146 hasConceptScore W4384341146C112613896 @default.
• W4384341146 hasConceptScore W4384341146C159110408 @default.
• W4384341146 hasConceptScore W4384341146C178790620 @default.
• W4384341146 hasConceptScore W4384341146C181199279 @default.
• W4384341146 hasConceptScore W4384341146C185592680 @default.
• W4384341146 hasConceptScore W4384341146C21951064 @default.
• W4384341146 hasConceptScore W4384341146C2776730177 @default.
• W4384341146 hasConceptScore W4384341146C2777990680 @default.
• W4384341146 hasConceptScore W4384341146C2778269047 @default.

• next